Search

Copyright of Archives of Cardiovascular Diseases is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Cites a study examining the effects of modified cyclodextrins (CD) hydroxypropyl-β-CD and methyl-β-CD on cDNA-expressed human cytochrome P-450 (CYP) activities. Ability of modified CD to inhibit the activities of CYP2C19 and CYP3A4; Enhancement by CD of the CYP2C9 activity by 140 to 176 percent; Inhibition by methyl-β-CD of CYP1A2 and CYP2D6 at higher concentrations.